Dark
Light
System
Institutional Investment Manager
Camber Capital Management LP
Camber Capital Management LP (CIK: 0001444043) incorporated in Delaware, located at 101 Huntington Avenue, Boston, MA. Institutional holdings reported to the SEC.

Institutional Holdings (2015Q1)
Portfolio Summary: 36 holdings with a total value of $1,400,537,000.
#
Name
Shares
Value ($)
%
Options
Notes
1 SPDR S&P 500 ETF TR 1,000,000 206,430,000 14.74% Put
2 TEVA PHARMACEUTICAL INDS LTD 1,650,000 102,795,000 7.34%
3 MASIMO CORP COM 2,700,000 89,046,000 6.36%
4 MEDICINES CO 2,500,000 70,050,000 5.00%
5 GENOMIC HEALTH INC COM 2,100,000 64,155,000 4.58%
6 EXPRESS SCRIPTS HLDG CO 700,000 60,739,000 4.34%
7 ARIAD PHARMACEUTICALS INC 7,000,000 57,680,000 4.12%
8 UNIVERSAL AMERN CORP NEW 5,234,898 55,909,000 3.99%
9 AMAG PHARMACEUTICALS INC COM 1,018,246 55,657,000 3.97%
10 ORTHOFIX INTERNATIONAL NV 1,500,000 53,835,000 3.84%
11 LABORATORY CORP AMER HLDGS 400,000 50,436,000 3.60%
12 LIVANOVA PLC 750,000 48,690,000 3.48%
13 SELECT MED HLDGS CORP COM 3,000,000 44,490,000 3.18%
14 ABBVIE INC 750,000 43,905,000 3.13%
15 KERYX BIOPHARMACEUTICALS INCORPORATED 3,000,000 38,190,000 2.73%
16 BRUKER CORP 2,000,000 36,940,000 2.64%
17 KINDRED HEALTHCARE INC 1,500,000 35,685,000 2.55%
18 SEQUENOM INC 9,000,000 35,550,000 2.54%
19 CONMED CORP 670,943 33,876,000 2.42%
20 ARENA PHARMACEUTICALS INC 7,500,000 32,775,000 2.34%
21 AMARIN CORP PLC 12,000,000 28,080,000 2.00%
22 GENMARK DIAGNOSTICS INC COM 1,482,662 19,245,000 1.37%
23 TREVENA INC 2,870,000 18,712,000 1.34%
24 CROSS CTRY HEALTHCARE INC COM 1,422,565 16,872,000 1.20%
25 EPIRUS BIOPHARMA 1,847,500 16,535,000 1.18%
26 BIOSCRIP INC 3,000,000 13,290,000 0.95%
27 ANGIODYNAMICS INC 728,483 12,960,000 0.93%
28 ALLSCRIPTS HEALTHCARE 1,000,000 11,960,000 0.85%
29 BIOLASE INC 7,388,867 11,283,000 0.81%
30 PROTALIX BIOTHERAPEUTICS INC 9,000,000 6,904,000 0.49% PRN
31 INVITAE CORP 400,000 6,704,000 0.48%
32 ORASURE TECHNOLOGIES INC 864,223 5,652,000 0.40%
33 CARDICA INC 8,374,846 5,274,000 0.38%
34 TARGACEPT INC 1,560,000 4,633,000 0.33%
35 PROTALIX BIOTHERAPEUTICS INC 2,000,000 3,560,000 0.25%
36 INOVIO PHARMACEUTICALS INC 250,000 2,040,000 0.15%

Portfolio data is normalized using SEC Form 13F filings, including the Original 13F-HR (0001546927-15-000145, filed 2015.05.15).

From 2023-01-03 onward, the SEC requires values to be reported in nearest dollars. Earlier filings reported values in thousands; therefore, positions shown as $0 in older filings may represent actual values between $0–$999.